A Calmer Way to Choose Your GLP-1 Program
The GLP-1 boom brought a flood of new telehealth programs — some genuinely great, a few you'd want to steer clear of. We're Barrett's Research, and we're here to help you tell them apart. We dug into every major program so you don't have to, and we share what we found in plain language, with nothing to hide.
Why we're here
Reviews that are genuinely on your side
If you've ever searched for the “best GLP-1 program,” you've probably noticed something frustrating: a lot of those lists are really just advertising in a nicer outfit, with whoever pays the most landing at the top. That never sat right with us, so we built Barrett's Research to do the opposite — to rank programs on the things that actually matter to you, not to advertisers.
Our job is simple, and we take it seriously. If you're paying out of pocket for semaglutide or tirzepatide, we want to help you find a safe, legitimate, fairly priced program — and gently steer you away from the corner-cutting operations that always follow a fast-growing market. No hype, no scare tactics. Just a clear-eyed friend who's read the fine print.
How we're different
Three promises behind every review
We tell you the downsides too
Every review names the trade-offs. We'd rather you know the catch up front than discover it after you've paid.
No one can buy a better spot
A program can't pay its way to a higher score or a better ranking. The same criteria apply to everyone, every time.
We do the homework for you
We verify licenses, check credentials in the NPI registry, and watch FDA enforcement actions ourselves — so you don't have to.
What we cover
Everything you need to decide — not just a ranking
Program reviews you can trust
We work through every major GLP-1 telehealth program ourselves and score each one against the same published rubric — so you're comparing apples to apples.
A watchful eye on safety
We keep track of FDA notices, recalls, and side-effect data across the market, and we tell you plainly what it means for your choice.
Help spotting the real ones
Simple checks and guides that let you confirm a program's licensing and pharmacy sourcing before you ever hand over a card number.
Honest cost breakdowns
What you'll actually pay each month — consults, labs, and the small fees that hide in the fine print — laid out so there are no surprises later.
Plain-language guides
Friendly, evidence-based explainers on GLP-1 medications, dosing, and what to expect — written for real people, not pharmacists.
What we stand for
The standards we hold ourselves to
Every page here rests on five simple commitments. We spell them out in full in our editorial policy, but here they are in short.
The people behind Barrett's Research
A small, independent team that does its own homework
Rihab Yassin, Ph.D.
Founder & Publisher · Health technology researcher
Barrett's Research is an independent publisher with no ownership ties to any GLP-1 program, pharmacy, or drug maker. That independence is the whole point. Before anything clinical goes live, it's reviewed by board-certified physicians and pharmacists — so the health guidance you read here has been checked by people who actually do this for a living.
Say hello
Tips, corrections, and questions are always welcome
We'd genuinely love to hear from you — whether you've spotted something we got wrong, have a tip about a program, or just have a question we can help with.
News tips
tips@glp1compass.com
Corrections
corrections@glp1compass.com
Ethics & partnerships
ethics@glp1compass.com
Barrett's Research shares educational information only — it isn't a substitute for medical advice. Please talk with a qualified healthcare provider before starting any medication. The contact addresses above are placeholders for this demonstration site.
Not sure which program is the right fit?
Answer six quick questions and we'll point you to the programs that suit your budget, your insurance, and how you want to be cared for.